Monday - Friday 8am to 4:30pm After hours or weekends if required by protocol
MAKE AN APPOINTMENT
Horario de oficina
Lunes - Vienes 8 am a 4.30 pm Fuera de horario o fines de semana si lo requiere el protocolo
CONCIERTE UNA CITA
Clinical Trials We Offer
Age group: From 12 years of ageGender: Male or FemaleDuration: Up to 34 weeks approximately (8.5 months)
Compensation provided.A study to investigate the safety, immunogenicity, and relative vaccine efficacy of mRNA-1283.222 injection compared with mRNA-1273.222 injection in participants ≥12 years of age to prevent COVID-19
Age group: From 18 to 75 years oldGender: Male or FemaleDuration: Up to 1 year, approximately
Compensation provided.Crohn’s disease (CD) is characterized by transmural inflammation with ulcerative lesions affecting any site within the gastrointestinal tract, with the most frequent involvement of the terminal ileum, often. combined with inflammation in the colon.
Age group: From 12 years oldGender: Male or FemaleDuration: Up to 24 weeks approximately
Compensation provided.For patients with rebound of COVID-19 symptoms and positive PCR test A Study to Learn About a Repeat 5-Day Treatment with Nirmatrelvir/Ritonavir in People with Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment with Nirmatrelvir/Ritonavir.
Age: From 18 to 50 years oldGender: FemaleDuration: Up to 2 years approximately
A Phase 3 Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis who Are at Risk for Pregnancy.
Age group: From 18 to 65 years oldGender: Male or FemaleDuration: Up to 34 weeks approximately (8.5 months)
Compensation provided.Lupus is a disease that occurs when your body’s immune system is active in a way that can injure your own healthy tissues and organs. There is no cure for lupus, but most patients receive treatments to help reduce symptoms and reduce or prevent damage to internal organs. Current treatments may be helpful or partly helpful in many cases of lupus.
Age: 6 to 17 years oldGender: Male or FemaleDuration: Up to 52 weeks approximately
Compensation provided.Psoriasis is an autoimmune disease; a condition in which the immune system mistakenly attacks its own body. There are many types of psoriasis, and your child is suffering from moderate to severe chronic plaque or mixed guttate/plaque psoriasis.
Age group: 6 to 17 years oldGender: Male or FemaleDuration: Up to 52 weeks approximately
Compensation provided.Atopic Dermatitis is a long lasting and very itchy inflammatory skin disease that often comes and goes. It can cause areas of dry, thickenes, raised and red skin that may crust and/or ooze. Up to 30% of children have AD at some point, and 2% to 10% of adults have AD. Although there is no cure, treatments may help control symptoms.
Age group: From 18 years oldGender: Female or MaleDuration: Up to 52 weeks approximately For patients with active psoriatic arthritis
Compensation provided.A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in Anti-TNF Experienced Subjects with ActivePsoriatic Arthritis I
Age group: From 18 years oldGender: Male or FemaleDuration: Up to 52 weeks approximately
Compensation provided.A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in Anti-TNF Naïve Subjects with Active Psoriatic Arthritis II.
Age group: From 40 to 65 years oldGender: FemaleDuration: Up to 36 weeks approximately
Compensation provided.This is a pivotal phase 3 study to assess the efficacy and safety of elinzanetant for the treatment of vasomotor symptoms (VMS) related to menopause.
Current Clinical Research Study Request
Monday - Friday 8am to 4:30pm
After hours or weekends if required by protocol
Palmetto Medical Plaza 7100 West 20th Avenue, Suite 411 Hialeah, FL 33016
Copyright © 2022 Desarrollado por: